Literature DB >> 12800806

Competition between acetylcholine and a nondepolarizing muscle relaxant for binding to the postsynaptic receptors at the motor end plate: simulation of twitch strength and neuromuscular block.

Vladimir Nigrovic1, Anton Amann.   

Abstract

UNLABELLED: The goal of the study was to simulate twitch strength and neuromuscular block produced by nondepolarizing muscle relaxants.
METHODS: In the proposed model, affinities of the two binding sites at a single postsynaptic receptor for acetylcholine (A) and the muscle relaxant (D) define the formation of three complexes with A only, three complexes with D only, and two complexes with both A and D. Twitch strength was postulated to be a function of the receptors with both binding sites occupied by A, and two constants. Neuromuscular block (NMB) was calculated from NMB = 1-twitch.
RESULTS: Stimulus-induced release of A results in rapid, but transient, changes in the concentrations of free A, the eight complexes, and the unoccupied receptors. Muscle relaxants that display either a congruous or an inverse pattern of affinities for the binding sites relative to those of A produce NMB vs. [D] curves with slightly different slopes but markedly different estimates for IC50. Depending on the number of activated receptors at the end plates of muscle fibers, the simulations represent the distributions of contracting fibers in a whole muscle.
CONCLUSION: Simulations of competition between A and D for binding to two sites at a receptor reveal that the potencies of muscle relaxants, defined by IC50, and the slopes of the NMB vs. [D] curves depend on (1) the affinities of D for the two binding sites, (2) the orientation of the affinities relative to those of A, and (3) the affinities of A for the same two sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800806     DOI: 10.1023/a:1023245409315

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  16 in total

1.  An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs.

Authors:  A F Kopman; M M Klewicka; G G Neuman
Journal:  Anesth Analg       Date:  2000-05       Impact factor: 5.108

Review 2.  Acetylcholinesterase.

Authors:  T L Rosenberry
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

Review 3.  Side effects of nondepolarizing muscle relaxants: relationship to their antinicotinic and antimuscarinic actions.

Authors:  E S Vizi; B Lendvai
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

4.  A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.

Authors:  F Donati; C Meistelman
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

5.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

6.  Differing potencies of muscle relaxants on rat and guinea-pig phrenic nerve diaphragm preparations.

Authors:  E G Bradshaw; N J Harper; B J Pleuvry; C Y Modla
Journal:  J Pharm Pharmacol       Date:  1986-08       Impact factor: 3.765

7.  Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.

Authors:  G H Fletcher; J H Steinbach
Journal:  Mol Pharmacol       Date:  1996-05       Impact factor: 4.436

8.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

9.  d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor.

Authors:  S E Pedersen; J B Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Quantitative simulation of endplate currents at neuromuscular junctions based on the reaction of acetylcholine with acetylcholine receptor and acetylcholinesterase.

Authors:  T L Rosenberry
Journal:  Biophys J       Date:  1979-05       Impact factor: 4.033

View more
  3 in total

1.  Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors.

Authors:  Shashi B Bhatt; Anton Amann; Vladimir Nigrovic
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-03       Impact factor: 2.745

2.  Simulation of the reversal of neuromuscular block by sequestration of the free molecules of the muscle relaxant.

Authors:  Vladimir Nigrovic; Shashi B Bhatt; Anton Amann
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-09-21       Impact factor: 2.410

3.  The relationship between twitch depression and twitch fade during neuromuscular block produced by vecuronium: correlation with the release of acetylcholine.

Authors:  Shashi B Bhatt; Jack Kohl; Anton Amann; Vladimir Nigrovic
Journal:  Theor Biol Med Model       Date:  2007-07-16       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.